SI1976522T1 - Farmacevtski sestavek, ki vsebuje montelukast - Google Patents

Farmacevtski sestavek, ki vsebuje montelukast

Info

Publication number
SI1976522T1
SI1976522T1 SI200631643T SI200631643T SI1976522T1 SI 1976522 T1 SI1976522 T1 SI 1976522T1 SI 200631643 T SI200631643 T SI 200631643T SI 200631643 T SI200631643 T SI 200631643T SI 1976522 T1 SI1976522 T1 SI 1976522T1
Authority
SI
Slovenia
Prior art keywords
pharmaceutical composition
composition containing
containing montelukast
montelukast
pharmaceutical
Prior art date
Application number
SI200631643T
Other languages
English (en)
Other versions
SI1976522T2 (sl
Inventor
Vesna Kroselj
Renata Osolnik
Turk Urska
Bevec Franci
Original Assignee
Krka, Tovarna Zdravil, D.D., Novo Mesto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37734296&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI1976522(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from EP05113112A external-priority patent/EP1803457A1/en
Application filed by Krka, Tovarna Zdravil, D.D., Novo Mesto filed Critical Krka, Tovarna Zdravil, D.D., Novo Mesto
Publication of SI1976522T1 publication Critical patent/SI1976522T1/sl
Publication of SI1976522T2 publication Critical patent/SI1976522T2/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SI200631643T 2005-12-30 2006-12-20 Farmacevtski sestavek, ki vsebuje montelukast SI1976522T2 (sl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP05113112A EP1803457A1 (en) 2005-12-30 2005-12-30 Pharmaceutical composition containing montelukast
EP06116654 2006-07-05
EP06830764.4A EP1976522B2 (en) 2005-12-30 2006-12-20 Pharmaceutical composition containing montelukast
PCT/EP2006/070045 WO2007077135A1 (en) 2005-12-30 2006-12-20 Pharmaceutical composition containing montelukast

Publications (2)

Publication Number Publication Date
SI1976522T1 true SI1976522T1 (sl) 2013-10-30
SI1976522T2 SI1976522T2 (sl) 2019-11-29

Family

ID=37734296

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200631643T SI1976522T2 (sl) 2005-12-30 2006-12-20 Farmacevtski sestavek, ki vsebuje montelukast

Country Status (7)

Country Link
EP (1) EP1976522B2 (sl)
EA (1) EA021960B1 (sl)
ES (1) ES2426443T3 (sl)
PL (1) PL1976522T5 (sl)
PT (1) PT1976522E (sl)
SI (1) SI1976522T2 (sl)
WO (1) WO2007077135A1 (sl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3449928A1 (en) 2005-11-28 2019-03-06 Imaginot Pty Ltd. Oral therapeutic compound delivery system
WO2009120885A2 (en) * 2008-03-26 2009-10-01 Taro Pharmaceuticals U.S.A., Inc. Stabilizing lipid compositions for oral pharmaceutical agents
WO2009122187A2 (en) * 2008-04-03 2009-10-08 Cipla Limited Pharmaceutical composition
WO2009153305A2 (en) * 2008-06-19 2009-12-23 Sandoz Ag Pharmaceutical compositions of montelukast sodium
TR201009398A2 (tr) * 2010-11-11 2012-05-21 Bi̇lgi̇ç Mahmut Fiziksel özellikleri geliştirilmiş tablet formülasyonları
CN103040784A (zh) * 2012-12-26 2013-04-17 深圳致君制药有限公司 一种孟鲁司特钠片组合物及其制备方法
CN104644564A (zh) * 2013-11-25 2015-05-27 天津汉瑞药业有限公司 一种含孟鲁司特钠的稳定的颗粒制剂及其制备方法
CN104840427B (zh) * 2014-02-13 2017-09-29 长春海悦药业股份有限公司 一种含有孟鲁司特钠的药物组合物

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5565473A (en) 1990-10-12 1996-10-15 Merck Frosst Canada, Inc. Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists
TW448160B (en) 1993-12-28 2001-08-01 Merck & Co Inc Novel dicyclohexylamine salt and process for the preparation of leukotriene antagonists
WO1997016173A1 (en) 1995-11-02 1997-05-09 Merck Frosst Canada Inc. New technology for wet granulation
PT1283036E (pt) * 1998-11-13 2008-03-06 Jagotec Ag Inalador de pó seco de dose múltipla com um reservatório de pó
MY148466A (en) 2001-10-26 2013-04-30 Merck Frosst Canada Ltd Granule formulation
AU2003209043A1 (en) 2002-02-07 2003-09-02 Dr. Reddy's Laboratories Ltd. Novel anhydrous amorphous forms of montelukast sodium salt
GB0204772D0 (en) 2002-02-28 2002-04-17 Phoqus Ltd Pharmaceutical dosage forms
WO2003077825A2 (en) * 2002-03-12 2003-09-25 Microdose Technologies, Inc. Site specific delivery of co-administered drugs via inhalation
US20040265375A1 (en) † 2003-04-16 2004-12-30 Platteeuw Johannes J. Orally disintegrating tablets
GB0312148D0 (en) * 2003-05-28 2003-07-02 Aventis Pharma Ltd Stabilized pharmaceutical products
US8450491B2 (en) 2003-06-06 2013-05-28 Morepen Laboratories Limited Method for the preparation of montelukast acid and sodium salt thereof in amorphous form
CA2541994A1 (en) * 2003-10-10 2005-05-06 Arjanne Overeem Solid-state montelukast
GB0326632D0 (en) * 2003-11-14 2003-12-17 Jagotec Ag Dry powder formulations
ES2940341T3 (es) 2004-01-20 2023-05-05 Novartis Ag Formulación y proceso de compresión directa
WO2005075427A2 (en) 2004-01-30 2005-08-18 Teva Pharmaceutical Industries Ltd. Montelukast sodium polymorphs
KR20060117356A (ko) * 2004-01-30 2006-11-16 테바 파마슈티컬 인더스트리즈 리미티드 몬테루카스트 유리산 다형체
EP1711166A1 (en) 2004-02-03 2006-10-18 Chemagis Ltd. Stable amorphous forms of montelukast sodium
US7189853B2 (en) 2004-04-15 2007-03-13 Dr. Reddy's Laboratories Limited Process for the preparation of [R-(E)-1-[[[1-[3-[2-[7-chloro-2-quinolinyl]ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]cyclopropaneacetic acid (Montelukast) and its pharmaceutically acceptable salts
US7501517B2 (en) 2004-04-30 2009-03-10 Synthon Ip, Inc. Process for making montelukast and intermediates therefor
CN1287792C (zh) 2004-08-30 2006-12-06 鲁南制药集团股份有限公司 孟鲁司特钠的分散片剂型
US20060105039A1 (en) * 2004-10-21 2006-05-18 Jin-Wang Lai Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
ITMI20050247A1 (it) 2005-02-18 2006-08-19 Chemi Spa Processo per la preparazione di montelukast
CA2616129A1 (en) 2005-07-20 2007-01-25 Dr. Reddy's Laboratories Ltd. Preparation of montelukast

Also Published As

Publication number Publication date
PL1976522T5 (pl) 2019-12-31
EP1976522B2 (en) 2019-07-03
EA200801614A1 (ru) 2008-10-30
WO2007077135A1 (en) 2007-07-12
PT1976522E (pt) 2013-09-09
EA021960B1 (ru) 2015-10-30
PL1976522T3 (pl) 2013-11-29
ES2426443T3 (es) 2013-10-23
EP1976522B1 (en) 2013-06-05
SI1976522T2 (sl) 2019-11-29
EP1976522A1 (en) 2008-10-08

Similar Documents

Publication Publication Date Title
HUS1400051I1 (hu) Lurazidont tartalmazó gyógyászati készítmény
GB0513692D0 (en) Novel pharmaceutical compositions
EP1909576A4 (en) NEW PHARMACEUTICAL COMPOUNDS
EP2025337A4 (en) EXTERNAL PHARMACEUTICAL COMPOSITION
EP2005959A4 (en) EXTERNAL PHARMACEUTICAL COMPOSITION
EP2005958A4 (en) TOPICAL PHARMACEUTICAL COMPOSITION
ZA200708580B (en) Composition containing anti-dementia drug
ZA200708705B (en) Pharmaceutical composition
IL187748A0 (en) Pharmaceutical compositions containing misoprostal
IL188352A0 (en) Pharmaceutical compositions
ZA200804103B (en) Pharmaceutical compositions
SI1976522T1 (sl) Farmacevtski sestavek, ki vsebuje montelukast
EP1937255A4 (en) PHARMACEUTICAL COMPOSITION
IL185602A0 (en) Pharmaceutical compositions containing acarbose
EP1862184A4 (en) PHARMACEUTICAL COMPOSITION
GB0522045D0 (en) Pharmaceutical compositions
IL192091A0 (en) Pharmaceutical compositions
EP1845944A4 (en) PHARMACEUTICAL COMPOSITIONS
HUP0500813A2 (en) Pharmaceutical composition containing violaceae extract
ZA200803566B (en) Pharmaceutical compositions
GB0514259D0 (en) Pharmaceutical compositions
ZA200808768B (en) Pharmaceutical composition containing the NMB0606 protein
ZA200805355B (en) Pharmaceutical compositions containing protein NMA0939
ZA200800392B (en) Pharmaceutical composition
ZA200803112B (en) Pharmaceutical composition